1033.0500 -1.45 (-0.14%)
NSE Sep 17, 2025 09:40 AM
Volume: 61,553
 

1033.05
-0.14%
IDBI Capital
While the Gross margins have risen to 65.1% Vs 63.9% in Q2FY17, given the strong launches it looked a bit muted. EBITDA margins were at 24.7% We reduce our FY18E/19E estimates and TP (Rs505, 22x FY19E EPS). Key Highlights and Investment Rationale...
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended